LotusDx Ltd

LotusDx is a medical technology company developing rapid, at-home diagnostic tests for sexually transmitted infections (STIs) such as chlamydia and gonorrhoea. The company’s solution is designed to provide results in approximately 15 minutes using a user-administered urine sample, eliminating the need for traditional clinic visits or the time-consuming process of mailing samples to a laboratory. By integrating these tests into a digital platform, the company aims to facilitate discreet and efficient disease detection, directly connecting users with healthcare professionals, pharmacies, and support services to ensure timely access to treatment and advice.

This technology addresses significant barriers in current sexual health testing pathways, including long waiting times, privacy concerns, and the social stigma that can discourage screening. By offering an accessible and intuitive testing experience, LotusDx aims to reduce infection transmission rates and improve public health outcomes for asymptomatic individuals who might otherwise delay testing. The company, which maintains research and development operations at the ONE BioHub in Aberdeen, has been recognized for its innovative approach through various industry awards, including the Social Impact Prize at the 2025 Converge Awards.